Ensysce Biosciences, Inc. Warrant 06/30/2026

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch ENSCW and buy or sell other stocks, ETFs, and their options commission-free!

About ENSCW

Ensysce Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of solutions for severe pain relief while reducing the fear of and the potential for misuse and overdose. The firm's Trypsin Activated Abuse Protection and Multi-Pill Abuse Resistance platforms are in the process of developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. 

CEO
D. Lynn Kirkpatrick, PhD
CEOD. Lynn Kirkpatrick, PhD
Employees
Employees
Headquarters
La Jolla, California
HeadquartersLa Jolla, California
Founded
2003
Founded2003
Employees
Employees

ENSCW Key Statistics

Market cap
Market cap
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
20.85K
Average volume20.85K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$0.03
52 Week high$0.03
52 Week low
$0.005
52 Week low$0.005

Stock Snapshot

As of today, Ensysce Biosciences, Inc. Warrant 06/30/2026(ENSCW) shares are valued at $0.01.

Ensysce Biosciences, Inc. Warrant 06/30/2026(ENSCW) stock opened on 2025-12-10 at —. The price climbed to — and dipped to —.

Ensysce Biosciences, Inc. Warrant 06/30/2026(ENSCW) shares are trading with a volume of 0, against a daily average of 20.85K.

During the past year, Ensysce Biosciences, Inc. Warrant 06/30/2026(ENSCW) stock moved between $0.01 at its lowest and $0.03 at its peak.

During the past year, Ensysce Biosciences, Inc. Warrant 06/30/2026(ENSCW) stock moved between $0.01 at its lowest and $0.03 at its peak.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.